Clinical Trial Update: Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection

View source ↗

Summary

Completed clinical trial update addressing denosumab-related bone and joint infection and osteomyelitis, including adverse events observed in the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteomyelitis

Drugs mentioned

• Prolia (denosumab)
• Xgeva (denosumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Bone and Joint Infection, Osteomyelitis | Status: COMPLETED